Apatinib resensitizes cisplatin-resistant non-small cell lung carcinoma A549 cell through reversing multidrug resistance and suppressing ERK signaling pathway. - Concepedia

Concepedia

Publication | Closed Access

Apatinib resensitizes cisplatin-resistant non-small cell lung carcinoma A549 cell through reversing multidrug resistance and suppressing ERK signaling pathway.

29

Citations

0

References

2017

Year

Z-L Liu, B-J Jin, Cheng Cg, Zhang Fx, Wang Sw, Y Wang, Wu B

Abstract

Apatinib can restore the sensitivity of A549/DDP cells to DDP by down-regulating the expression level of MDR1 and inhibiting the activity of the ERK signaling pathway.